Full Text View
Tabular View
No Study Results Posted
Related Studies
Familial Aggregation of Barrett's Esophagus
This study has been completed.
Study NCT00058877   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: April 14, 2003   Last Updated: February 5, 2007   History of Changes

April 14, 2003
February 5, 2007
 
 
 
 
Complete list of historical versions of study NCT00058877 on ClinicalTrials.gov Archive Site
 
 
 
Familial Aggregation of Barrett's Esophagus
Familial Aggregation of Barrett's Esophagus

This research study is trying to determine whether Barrett's esophagus and associated esophageal cancers, specifically esophageal adenocarcinoma are inherited in certain families. Persons who are affected with Barrett's esophagus or esophageal cancer (adenocarcinoma type) are asked to complete a questionnaire that determines their habits and asks a detailed family history. Family members of patients seen at University Hospitals of Cleveland are also being recruited for screening tests of their esophagus. The investigators plan to eventually screen family members at all participating institutions. This research will eventually lead to the identification of inherited genetic changes that cause Barrett's esophagus and esophageal cancer. It will help the investigators develop better methods for preventing or identifying esophageal cancer at an early curable stage.

 
 
Observational
Screening, Cross-Sectional, Defined Population, Retrospective/Prospective Study
  • Barrett's Esophagus
  • Esophageal Neoplasm
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
650
 
 

Eligible cases will be defined as those patients and their family members who meet the following criteria:

  • Barrett’s esophagus confirmed by review of pathology and endoscopy report or adenocarcinoma of the esophagus or family members of person with Barrett's esophagus or adenocarcinoma of the esophagus.
  • Male or female age 18 or older at time of enrollment or male or female less than 18 years of age at time of enrollment with parental consent.
  • Ability to give informed consent, if patient is age 18 or older.
  • No history of radiation to the chest or abdomen.
  • No history of chemotherapy in the year preceding the initial diagnosis of Barrett’s esophagus or esophageal adenocarcinoma.
Both
 
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00058877
 
FABE
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 
 
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
February 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP